Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00541_DB00619_nanopub.RAGRFe0OniF8uypENG7nMAuwwB0vTT1pXNaQshovp_F2A#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00541_DB00619 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00541_DB00619 label "DDI between Vincristine and Imatinib - Imatinib, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Imatinib is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB00619]" assertion.
- drugbank_resource:DB00541_DB00619 identifier "drugbank_resource:DB00541_DB00619" assertion.
- drugbank_resource:DB00541_DB00619 title "DDI between Vincristine and Imatinib - Imatinib, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Imatinib is initiated, discontinued or dose changed." assertion.
- drugbank:DB00541 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB00619 assertion.
- drugbank:DB00619 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB00619 assertion.